Revolutionize patient care through clinically relevant molecular testing


Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices. 

While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, rapid PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.

Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.


Educational resources by disease area

The respiratory landscape is ever-evolving, seasonal, and unpredictable.


Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.

Read more › | 6 min read

Learn about the detection of antibiotic resistance genes through molecular techniques.

Antibiotic resistance

The growing threat of antibiotic resistance spurs new molecular technology that bears both advantages and disadvantages.

Read blog › | 9 min read

Discover the new frontier of using PCR for the detection of urinary tract infections.


Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this novel testing method.

Read blog › | 7 min read

Use PCR to detect STIs and a range of both commensal and pathogenic microbes.

Women’s health

From the detection of STIs to both commensal and pathogenic microbes, PCR delivers quick results from a single sample.

Watch webinar › | 76 min watch

Swab and tube sample for testing

The importance of distinguishing between aerobic vaginitis and bacterial vaginosis

It’s important to differentiate bacterial vaginosis (BV) from aerobic vaginitis (AV), an ongoing challenge with traditional methods. A molecular testing solution based on different bacterial combinations may allow distinction of BV versus AV, which has clinical significance with respect to treatment and care. This webinar presents a solution that could be employed to mitigate misdiagnosis of AV for BV. 

Watch now

Learn more about how
to implement tests in your lab

Learn more ›

Demystifying the development
and implementation of molecular
tests in a clinical laboratory

Learn more › | 5 min read

7 things to know before
establishing an LDT

Learn more › | 3 min read

Style Sheet for Global Design System